• Info
  • Insider Ownership

Insider Trading & Ownership of Sarah A. Teichmann

Location
Pleasanton, CA
Summary
The estimated net worth of Sarah A. Teichmann is at least $519,799 dollars as of 27 Feb 2026. Sarah A. Teichmann is the Director of 10x Genomics, Inc. and owns shares of 10x Genomics, Inc. (TXG) stock worth about $519.8K.
Signature
/s/ Randy Wu, as Attorney-in-Fact for Sarah A. Teichmann
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Sarah A. Teichmann and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Sarah A. Teichmann has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $519,799.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: 10x Genomics, Inc. ($519,799).
  • Past-year value change for that position: -$147,108.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Sarah A. Teichmann

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TXG 10x Genomics, Inc. Director $519,799 -$147,108 -22% 25 Feb 2026

Insider Transactions Reported by Sarah A. Teichmann:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored